triple-negative breast cancer(English)
- the most fatal type in breast cancer. Due to the lack of relevant targeted therapy targets, in addition to surgery, chemotherapy is still the most common treatment option. It is heterogeneous, and different patients have different sensitivity to chemotherapy. Only some patients will benefit from chemotherapy, so the neoadjuvant chemotherapy is controversial in the treatment
- CD95L, cIAP, CLL, COR, CRC, CYLD, DAI, DIK, DR, EMT, ESCC, FADD, 5-FU, GEO, GLUL, HCC, HMGB1, HNSCC, HSP90, ICD, ICE, IFN, IL, KD, KIRC, KO, LRR, LRRK, MDSC, MLKL, NK, NKT, NLR, NOD, NPC, OS, OSCC, PARP, PDA, PFS, PGAM5, PGE2, PKC, PKK, PRR, RICK, RIP, RIP1, RIPK, RHIM, ROS, Roc, SgK288, SNP, Sp1, STS, TCGA, TAM, TLR, TME, TNBC, TNF, TNFR, TRAIL, TRADD, TRAF, TRIF, TSCC, Ub, UHRF1, WT, Zbp1, BGICC, BLIA, BLIS, LAR, MES, CNB, DFS, PD-L1, PST, TIL, AML, 5-aza-dC, CARD, CARDIAK
- Oncology, Woman /female, Mammary gland, Genetics
- https://doi.org…olb.2021.708052
- https://doi.org…cancers13092262
- https://doi.org…edicina59101875
- https://doi.org…2282-017-0781-0
- https://doi.org…dis.2021.10.007